Correction and Maintenance study of subcutaneous injections of R744 to predialysis patients ( Phase III, comparative study in comparison with epoetin beta).
Phase 3
- Conditions
- Renal anemia
- Registration Number
- JPRN-jRCT2080220401
- Lead Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Adult patients >=20 years of age
Pre dialysis patients
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy
- Secondary Outcome Measures
Name Time Method